🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 69 of 114

  1. Placebo

    AstraZeneca

    Irritable Bowel Syndrome With Constipation (IBS-C)

    phase 3 small molecule completed

    1 trial

  2. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Adult Attention Deficit Hyperactivity Disorder

    phase 3 small molecule completed

    1 trial

  3. Placebo

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  4. Placebo

    Takeda

    Diabetes

    phase 3 small molecule terminated

    1 trial

  5. Placebo

    Takeda

    Generalized Anxiety Disorder

    phase 3 small molecule completed

    1 trial

  6. Placebo

    Takeda

    Hypertension

    phase 3 small molecule terminated

    1 trial

  7. Placebo

    Takeda

    Hypoparathyroidism

    phase 3 small molecule completed

    1 trial

  8. Placebo

    Takeda

    Lennox Gastaut Syndrome (LGS)

    phase 3 small molecule completed

    1 trial

  9. Placebo

    Takeda

    Male Subjects With Chronic Constipation

    phase 3 small molecule completed

    1 trial

  10. Placebo

    Takeda

    Short Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  11. Placebo

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 3 small molecule active

    1 trial

  12. Placebo

    Laboratoire HRA Pharma

    Leber congenital amaurosis (LCA)

    phase 3 small molecule active

    1 trial

  13. Placebo

    SUPERNUS PHARMACEUTICALS, INC.

    Postpartum Depression

    phase 3 small molecule completed

    2 trials

  14. Placebo

    Amneal Pharma Europe Ltd

    Asthma

    phase 3 small molecule active

    1 trial

  15. Placebo

    Novartis Pharmaceuticals

    IC-MPGN

    phase 3 small molecule active

    1 trial

  16. Placebo

    Takeda

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    2 trials

  17. Placebo

    SUPERNUS PHARMACEUTICALS, INC.

    Epilepsies, Partial

    phase 3 small molecule completed

    1 trial

  18. Placebo

    Agios Netherlands B.V.

    Pyruvate Kinase Deficiency

    phase 3 small molecule completed

    1 trial

  19. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 small molecule completed

    1 trial

  20. Placebo

    Pfizer

    Ulcerative Colitis

    phase 3 small molecule completed

    1 trial

  21. Placebo

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    2 trials

  22. Placebo

    Mineralys Therapeutics

    Hypertension

    phase 3 small molecule completed

    2 trials

  23. Placebo

    SUPERNUS PHARMACEUTICALS, INC.

    ADHD

    phase 3 small molecule completed

    5 trials

  24. Placebo

    Takeda

    Healthy Volunteers

    phase 3 small molecule completed

    2 trials

  25. Placebo

    Regeneron UK Limited

    Gout

    phase 3 small molecule completed

    1 trial

  26. Placebo

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome With Constipation (IBS-C)

    phase 3 small molecule completed

    1 trial

  27. Placebo

    HALOZYME THERAPEUTICS, INC.

    Pancreatic Ductal Carcinoma

    phase 3 small molecule terminated

    1 trial

  28. Placebo

    Regeneron UK Limited

    Heterozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    1 trial

  29. Placebo

    Mochida Pharmaceutical Company,

    Hypertriglyceridemia

    phase 3 small molecule completed

    1 trial

  30. Placebo

    Takeda

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  31. Placebo

    Hoffmann-La Roche

    Non-Squamous Non-Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  32. Placebo

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    3 trials

  33. Placebo

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    phase 3 small molecule completed

    2 trials

  34. Placebo

    NEUROCRINE BIOSCIENCES INC

    Dyskinesia

    phase 3 small molecule completed

    1 trial

  35. Placebo

    Eli Lilly and Company

    Hepatocellular Carcinoma

    phase 3 mab completed

    1 trial

  36. Placebo

    Hoffmann-La Roche

    Schizophrenia

    phase 3 small molecule completed

    1 trial

  37. Placebo

    Milestone Pharmaceuticals

    Atrial Fibrillation

    phase 3 small molecule active

    1 trial

  38. Placebo

    Alnylam Netherlands B.V.

    Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

    phase 3 small molecule completed

    1 trial

  39. Placebo

    Alnylam Netherlands B.V.

    Primary Hyperoxaluria Type 1 (PH1)

    phase 3 small molecule completed

    1 trial

  40. Placebo

    Takeda

    Multiple Myeloma

    phase 3 small molecule completed

    1 trial

  41. Placebo

    Disc Medicine

    Erythropoietic Protoporphyria (EPP)

    phase 3 small molecule active

    1 trial

  42. Placebo

    AbbVie

    Psoriatic Arthritis

    phase 3 mab active

    1 trial

  43. Placebo

    Madrigal Pharmaceuticals EU Limited

    Non-Alcoholic Fatty Liver Disease

    phase 3 small molecule completed

    1 trial

  44. Placebo

    AbbVie

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

  45. Placebo

    Kalvista Pharmaceuticals (Ireland) Limited

    Hereditary Angioedema

    phase 3 small molecule completed

    1 trial

  46. Placebo

    Takeda

    Non-erosive Gastroesophageal Reflux Disease

    phase 3 small molecule completed

    1 trial

  47. Placebo

    Camp4 Therapeutics Corp

    Asthma

    phase 3 small molecule completed

    1 trial

  48. Placebo

    United Therapeutics Europe Ltd

    Idiopathic Pulmonary Fibrosis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.